Columbia University

Technology Ventures

CSL Research Acceleration Initiative

Thursday, February 25, 2021 - 5:00pm

CSL’s Research Acceleration Initiative aims to fast-track discovery of innovative biotherapies through partnerships between CSL and global research organizations.

The 2021 Research Acceleration Initiative will focus on research projects that span a CSL Therapeutic Area and a Focus Area, and that are amenable to or include a Modality listed below:

Therapeutic Area (emphasis on rare disease):

  • Immunology
  • Hematology
  • Respiratory
  • Cardiovascular/Metabolic
  • Transplant

Focus Areas:

  • Novel drug targets
  • Novel therapeutic candidates
  • Novel strategies for treating disease


  • Antibodies
  • ​​​​​​​Recombinant proteins
  • Cell and gene therapies
  • Small molecules not of interest

Successful applicants will receive up to $200K per year for 2 years (max $400K funding).

Researchers who wish to apply are required to submit a 300 word online pre-application by Feb. 25 to Sharon Ross (University City Science Center) at [email protected] Shortlisted applicants will then be invited to submit a detailed proposal in April.


Feb. 25: Deadline for “paper form” pre-applications (nonconfidential, 300-word project descriptions) due to Science Center  
March 12: Deadline for CSL- approved/accepted pre-applications to apply to RAI on-line portal
April 19: Selected applicants invited to submit a full application
May 16: Full application deadline for selected applicants